poisar

Stocks · News reference

Pharvaris Summarizes Clinical Data Presentations at ACAAI 2026 Annual Scientific Meeting

Fiscal.ai

Pharvaris presented new clinical and real-world data for its lead candidate, deucrictibant, at the American College of Allergy, Asthma & Immunology (ACAAI) 2026 Annual Scientific Meeting.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading